• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌转移潜能的评估:一种体内模型

Evaluation of metastatic potential in prostate carcinoma: an in vivo model.

作者信息

Angelucci Adriano, Gravina Giovanni Luca, Rucci Nadia, Festuccia Claudio, Muzi Paola, Vicentini Carlo, Teti Anna, Bologna Mauro

机构信息

Department of Basic and Applied Biology, University of L'Aquila, Medical School and Science and Technology School, Coppito-2, I-67100 L'Aquila, Italy.

出版信息

Int J Oncol. 2004 Dec;25(6):1713-20.

PMID:15547709
Abstract

Prostate cancer is frequently associated with bone metastases, which are in fact the main cause of morbidity and mortality for this tumor. To better investigate this process, animal models of bone and bone marrow metastases need to be developed. However, experimental prostate cancer bone metastases are difficult to be obtained in vivo, and some typical clinical patterns remain irreproducible. In this study, we injected PC3 prostate cancer cells into the left cardiac ventricle of nude mice, thus reproducing the basic biological phenomenon of tumor cell spreading in the arterious blood stream, and compared the outcome with direct injection of cells in the bone marrow cavity of the tibia. Mice were monitored by X-ray analysis. After 40 days, 100% of intratibially-injected and 64% of heart-injected mice revealed osteolytic lesions. The heart injection was then used to select PC3 cell subpopulations by serial inoculation and recovery from bone metastasis. One of the resulting cell populations, obtained by a second round of selection and denominated PCb2, showed a more invasive phenotype compared to parental PC3, both in vitro and in vivo. Although PCb2 cells had a growth rate comparable to that of PC3 cells, they generated a higher number of bone lesions in nude mice and crossed more easily the Matrigel barrier in vitro in the presence of several chemoattractants. This phenomenon was partially due to an increased capacity to adhere to laminin and to release MMP-2 at higher level relative to the original PC3 cells. This study demonstrates that heart injection of prostate cancer cells in nude mice may represent a good experimental model to investigate the pathophysiology of bone and bone marrow metastases in vivo.

摘要

前列腺癌常伴有骨转移,事实上这是该肿瘤发病和死亡的主要原因。为了更好地研究这一过程,需要建立骨和骨髓转移的动物模型。然而,实验性前列腺癌骨转移在体内难以获得,一些典型的临床模式仍无法重现。在本研究中,我们将PC3前列腺癌细胞注入裸鼠左心室,从而重现肿瘤细胞在动脉血流中扩散的基本生物学现象,并将结果与直接将细胞注入胫骨骨髓腔进行比较。通过X射线分析对小鼠进行监测。40天后,100%经胫骨内注射的小鼠和64%经心脏注射的小鼠出现溶骨性病变。然后通过连续接种和从骨转移灶中回收,利用心脏注射法筛选PC3细胞亚群。通过第二轮筛选获得的一个细胞群体命名为PCb2,与亲本PC3相比,在体外和体内均表现出更强的侵袭性表型。尽管PCb2细胞的生长速度与PC3细胞相当,但它们在裸鼠中产生更多的骨病变,并且在存在几种趋化因子的情况下,在体外更容易穿过基质胶屏障。这种现象部分归因于相对于原始PC3细胞,其黏附层粘连蛋白的能力增强以及释放更高水平MMP-2的能力增强。本研究表明,向裸鼠心脏注射前列腺癌细胞可能是一种在体内研究骨和骨髓转移病理生理学的良好实验模型。

相似文献

1
Evaluation of metastatic potential in prostate carcinoma: an in vivo model.前列腺癌转移潜能的评估:一种体内模型
Int J Oncol. 2004 Dec;25(6):1713-20.
2
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.人前列腺癌转移至人骨的严重联合免疫缺陷-人模型
Cancer Res. 1999 Apr 15;59(8):1987-93.
3
An in vivo model of prostate carcinoma growth and invasion in bone.前列腺癌在骨中生长和侵袭的体内模型。
Cell Tissue Res. 2002 Mar;307(3):337-45. doi: 10.1007/s00441-001-0503-x. Epub 2002 Feb 14.
4
The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.双膦酸盐奥帕膦酸盐在绿色荧光蛋白裸鼠模型中抑制骨骼前列腺癌进展。
Clin Cancer Res. 2006 Apr 15;12(8):2602-6. doi: 10.1158/1078-0432.CCR-05-2050.
5
[Establishment of bone metastasis model of prostate cancer in nude mice by intratibia injection of human prostate cancer cell line Du145].[通过胫骨注射人前列腺癌细胞系Du145建立裸鼠前列腺癌骨转移模型]
Zhonghua Nan Ke Xue. 2006 Feb;12(2):133-6.
6
Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.评估严重联合免疫缺陷(SCID)小鼠体内人胎儿骨植入物作为前列腺癌骨转移模型的情况。
Oncol Rep. 2006 Mar;15(3):519-24.
7
Development of an animal model for prostate cancer cell metastasis to adult human bone.前列腺癌细胞转移至成人生骨的动物模型的建立。
Anticancer Res. 2001 Mar-Apr;21(2A):971-8.
8
RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.核因子κB受体活化因子配体(RANKL)直接作用于表达核因子κB受体活化因子(RANK)的前列腺肿瘤细胞,并介导肿瘤转移基因的迁移和表达。
Prostate. 2008 Jan 1;68(1):92-104. doi: 10.1002/pros.20678.
9
Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.大鼠前列腺腺癌细胞扩散至骨骼并优先黏附于骨髓来源的内皮细胞。
Cancer Res. 1992 Sep 1;52(17):4613-9.
10
Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.I型胶原蛋白受体(α2β1)信号传导促进人前列腺癌细胞在骨内的生长。
Cancer Res. 2006 Sep 1;66(17):8648-54. doi: 10.1158/0008-5472.CAN-06-1544.

引用本文的文献

1
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth.双重 CXCR4 和 E-Selectin 抑制剂 GMI-1359 具有抗骨转移作用,并与多西他赛在前列腺癌细胞骨内生长中具有协同作用。
Cells. 2019 Dec 20;9(1):32. doi: 10.3390/cells9010032.
2
Basigin-2 upregulated by receptor activator of NF-κB ligand enhances lung cancer-induced osteolytic lesions.由核因子κB受体激活剂配体上调的基底膜联蛋白-2增强肺癌诱导的溶骨性病变。
Cancer Cell Int. 2016 Apr 2;16:28. doi: 10.1186/s12935-016-0302-9. eCollection 2016.
3
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.
KPT-330是一种强效且具有选择性的核输出蛋白1(XPO-1)抑制剂,在前列腺癌模型中显示出通过调节细胞周期蛋白D1和生存素的表达发挥抗肿瘤作用。
BMC Cancer. 2015 Dec 1;15:941. doi: 10.1186/s12885-015-1936-z.
4
XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).核输出选择性抑制剂(SINE)XPO1/CRM1可减少前列腺癌(PCa)临床前模型中的肿瘤扩散并提高总生存率。
J Hematol Oncol. 2014 Oct 5;7:46. doi: 10.1186/1756-8722-7-46.
5
Prostate cancer and bone: the elective affinities.前列腺癌与骨骼:选择性亲和关系。
Biomed Res Int. 2014;2014:167035. doi: 10.1155/2014/167035. Epub 2014 May 28.
6
Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.雌激素受体β1和β2在调节前列腺癌细胞系PC3中的增殖和骨转移基因方面具有相反的作用。
Mol Endocrinol. 2012 Dec;26(12):1991-2003. doi: 10.1210/me.2012.1227. Epub 2012 Oct 1.
7
EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.内皮祖细胞诱导的 EphA2 介导的间质-阿米巴样转化通过癌细胞相关成纤维细胞增强转移扩散。
J Mol Med (Berl). 2013 Jan;91(1):103-15. doi: 10.1007/s00109-012-0941-9. Epub 2012 Aug 19.
8
CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis.CCN3 调节骨转换,是骨骼转移的新型调节因子。
J Cell Commun Signal. 2012 Jun;6(2):73-85. doi: 10.1007/s12079-012-0161-7. Epub 2012 Mar 18.
9
Non-invasive microCT imaging characterization and in vivo targeting of BB2 receptor expression of a PC-3 bone metastasis model.非侵入性 microCT 成像特征分析及 BB2 受体在 PC-3 骨转移模型中的体内靶向性研究。
Mol Imaging Biol. 2012 Dec;14(6):667-75. doi: 10.1007/s11307-012-0540-8.
10
Quantification of mouse pulmonary cancer models by microcomputed tomography imaging.通过微型计算机断层扫描成像对小鼠肺癌模型进行定量分析。
Cancer Sci. 2009 Aug;100(8):1544-9. doi: 10.1111/j.1349-7006.2009.01199.x. Epub 2009 May 13.